| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |